by SEIU International

Obama's Health Reform Bill and its impact on the U.S. markets now available at Health Care report sand reports

According to a 2009 study by the World Health Organization, the U.S. health system ranks among the health systems of 200 countries 37th. The U.S. healthcare spending is to be in the world as one of the highest, accounting for 17.5% of GDP in 2009 to an average of 8% to 9% in the countries of the Organization for Economic Cooperation and Development compared (OECD).

This was an important factor in health care reform was needed, along with rising healthcare costs and health premium rates and the high number of uninsured (about 47 million or approximately 16% of the total population).

President Obama signed put healthcare reform takes effect March 2010, the quality and efficiency to improve health care, reduce address the inefficiency of the existing supply structure and the number of uninsured people in the U.S. The health care reform bill several provisions such as universal health insurance, cost containment, describes increasing insurance market competition, consumption tax on manufacturers of medical devices, drugs and lower costs for Medicare and Medicaid. The health reform provisions thus a direct impact on the U.S. healthcare industry and its players.

The report forecasts and analyzes the future effects of health reform on the U.S. health care. This includes both direct and indirect impact of the provisions of the pharmaceutical, medical devices and health insurance industry. Indirect impact on provisions, which do not apply specifically to these industries. Each section provides a strategic analysis of the impact of Obama's health reform on U.S. health reform structure.

What makes our reports so unique?

* We offer the longest chain of market segmentation in the industry are not many reports provide market split down to level 5

* We offer 10% matching. Usually, it is evident that customers do not find specific market information they are looking for. Our individual will ensure that you read the market information you are looking for and we get a loyal customer.

* We detailed market positioning, product positioning and competitive positioning result. Entry strategies, gaps and opportunities for all parties identified.

* Comprehensive market analysis for the following areas:

Drugs, medical devices, biotechnology, semiconductors and electronics, energy, and power supplies, food and beverages, chemicals, new materials, Industrial Automation and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R & D) companies.

Important questions answered

* What is the structure of the U.S. health care system and what are the pitfalls in the current system?

* What are the main provisions of the U.S. health reform?

* How would affect the provisions of the health reform U.S. healthcare industry in the near future?

* What are the driving forces and restrictions for different players in the U.S. healthcare industry in the near future will be?

* What are the possible consequences for the economy of the U.S. healthcare industry and its stakeholders such as pharmaceutical, medical device manufacturers and health insurance industry?

* What are implications of health reforms on the U.S. economy?

Powerful research and analysis

Analysts working with market sand markets from renowned publishers and market research companies worldwide come by their expertise and domain understanding. We get the facts from more than 22,000 news and information sources, a huge database with key industry participants and are based on our worldwide relationships with more than 900 market research companies. We at market sand markets, are inspired to grow to our customers by offering qualitative insights into business processes with our vast market intelligence repository.

Contents

1 Introduction

1.1 Key Take-Aways

1.2 Report Description

1.3 Stakeholder

1.4 Research Methodology

2 U.S. health care industry at a glance

2.1 Overview of health care in Germany

2.2 Health reform in the U.S.

2.2.1 Agenda of Obama's health care reform

2.2.2 Challenges for Health Care Reform Obama

2.2.3 Impact of Obama's health care reform to the Health Care Industry

2.2.3.1 impact on the health insurance industry

2.2.3.2 impact on the pharmaceutical and medical device industries

2.2.3.3 Empowerment of Health Care Consumers and their impact on U.S. economy

3 U.S. Health Care

3.1 Healthcare Structure in the U.S.

3.1.1 Reimbursement and financing

3.1.1.1 Public health insurance

3.1.1.1.1 Medicare

3.1.1.1.2 Medicaid

3.1.1.1.3 Other public systems

3.1.1.2 Private Health Insurance

3.1.1.2.1 employer-sponsored insurance

3.1.1.2.2 Private group insurance (individual market)

3.1.1.2.3 Private group insurance (cooperative)

3.1.2 Regulatory environment

3.1.2.1 Health Care Law

3.1.2.2 Regulators

3.1.2.2.1 The Center for Devices and Radiological Health (CDRH)

3.1.2.2.2 U.S. Food and Drug Administration (FDA)

3.2 Health expenditure

3.2.1 Total expenditure on health care

3.2.2 Per-capita spending on health care

3.2.3 Health Care budget and health reform

3.2.4 Obama's stimulus package for health

3.3 Need for Health Reform

3.3.1 Rising health care costs

3.3.2 unaffordable health insurance

3.3.3 Unequal health insurance

3.3.4 Lack of Health Care Quality

4 Obama's health reform

4.1 Obama's proposed strategies for reform in health care

4.1.1 Improving the affordability and accessibility of health care

4.1.2 improvement of public health

4.1.3 lower health care costs

4.1.4 Improving the quality of health care

4.2 Obama's health initiatives

4.2.1 Obama's health care reform

4.2.1.1 patient safety and affordable care Act, 2009

4.2.1.2 Health and Education Reconciliation Act 2010

4.2.1.3 Health Reform – Implementation Timeline

4.2.2 Other health initiatives

4.2.2.1 Children's Health Insurance Program Reauthorization Act, 2009 (CHIPRA)

4.2.2.2 American Recovery and Reinvestment Act, 2009

5 Impact of Obama's health reform provisions of the U.S. Health Care Industry

5.1 Impact on Medical Device Industry

5.1.1 Rate

5.1.2 Increased FDA compliance

5.1.3 Increased transparency by CER and prohibition of sunshine destination

5.1.4 Indirect effects

5.1.5 business implications for manufacturers of medical devices

5.2 Impact on Pharmaceutical Industry

5.2.1 Consumption taxes: a possible negative impact

5.2.2 lower drug prices through Medicare and deposit Medicaid

5.2.3 Discounts for new formulations of branded drugs

5.2.4 Increase inspection and compliance costs

5.2.5 12-year exclusivity for biologics regulatory pathway for biosimilars and New

5.2.6 cover the costs of clinical trials

5.2.7 implications for pharmaceutical companies and biotechnology industry

5.3 Impact on Insurance Industry

5.3.1 Medical loss ratio (MLR)

5.3.2 MANDATORY COVERAGE PROVISIONS

5.3.2.1 Guaranteed eligibility

5.3.2.2 Prohibition of annual and lifetime limits

5.3.2.3 Mandatory screening and vaccinations without cost-sharing

5.3.3 The annual fees and tax implications

5.3.4 Health Insurance Exchange

5.3.5 improvement of child care coverage

5.3.6 Cost containment provisions

5.3.7 Employers Play-or-pay policy

5.3.8 Business Impact of Insurance Economics

5.4 Impact on other stakeholders (beneficiaries and hospitals)

5.4.1 impact of health reform on beneficiaries

5.4.2 The impact of health reforms on hospitals

6 Economic impact of Obama's health reform

6.1 Economic impact

report sand reports, consisting of an online library of 10,000 reports, detailed market studies of more than 5000 accounts markets and 25 industry-specific websites. to report sandy reports proclaim Research Report on Obama's Health Reform Bill and its impact on the U.S. Health Care Markets (medicines, medical devices and health insurance) Market Research Report have in his shop. Browse all our market research details at ReportsandReports.com

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.